Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Clinical trial NCT02920541 · COMPLETED

Trial details

NCT number: NCT02920541
Sponsor: Institut de Recherches Internationales Servier
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2015-01-01
Primary completion: 2018-05-24
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.